KIRSTEN LAMPE: Open Payments
NPI 1275980716 · OVERLAND PARK, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$872 in 41 payments from 15 companies in 2025. Trend: 2023 $600 · 2024 $658 · 2025 $872
Food & beverage: $872
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $199 |
| ABBVIE INC. | 7 | $170 |
| PFIZER INC. | 4 | $69 |
| Ardelyx, Inc. | 3 | $65 |
| Otsuka America Pharmaceutical, Inc. | 3 | $63 |
| Lilly USA, LLC | 3 | $62 |
| Novo Nordisk Inc | 3 | $50 |
| Kowa Pharmaceuticals America, Inc. | 3 | $48 |
| Abbott Laboratories | 2 | $40 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $24 |
Products named: AIRSUPRA, UBRELVY, IBSRELA, REXULTI, MOUNJARO, ELIQUIS, ZORYVE, QULIPTA.
Industry payments across KS — which companies pay providers there.
